A recent publication [46] using integrated genomic sequencing shows gain-of-function mutations in JAK1, JAK3 and STAT5B in T cell prolymphocytic leukaemia (T-PLL), supporting the importance of JAK kinases for T cell lymphoma growth. This evidence concerns the gene JAK1 and T-cell non-Hodgkin lymphoma.